Novavax Inc and partner Serum Institute of India said on Monday; they received emergency use authorization for their COVID-19 vaccine in Indonesia, making it the first approval anywhere in the world for Novavax.
The shot will be sold under the brand name Covovax.
It has so far applied for EUA in various countries, including Canada; the UK, Australia, India and to the European Medicines Agency.
ALSO READ: Novavax: Covid vaccine 90% effective, plans to submit data to FDA in third quarter
The company, along with Japanese partner Takeda Pharmaceutical Co, said on Friday; it was preparing to seek regulatory approval for a rollout in Japan early next year.
Novavax has delayed filing for U.S. approval to the end of this year, and Politico reported last month that the company has faced production and quality problems.
The shot is a protein-based vaccine, and was shown to be more than 90% effective; including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based clinical trial.
In other news, Russia has fined seven internet giants a combined total of $2.6 million for failure to remove prohibited information; including content that promoted the usage of drugs, the country’s media watchdog has revealed.
Specifically, in a post on its Telegram channel on Monday; Roskomnadzor outlined the penalties handed down to companies that refuse to abide by the watchdog’s deletion requests.
The websites in question include US-based social networks Facebook ($998,000) and Twitter ($542,000); American search engine Google ($458,000), and Chinese video-sharing app TikTok ($58,000).
Russian social media networks Odnoklassniki ($56,000) and VKontakte ($42,000) were also fined; alongside the popular messaging app Telegram ($494,000).
